WO2011068944A1 - Sels liquides tétraioniques et leurs méthodes d'application - Google Patents

Sels liquides tétraioniques et leurs méthodes d'application Download PDF

Info

Publication number
WO2011068944A1
WO2011068944A1 PCT/US2010/058679 US2010058679W WO2011068944A1 WO 2011068944 A1 WO2011068944 A1 WO 2011068944A1 US 2010058679 W US2010058679 W US 2010058679W WO 2011068944 A1 WO2011068944 A1 WO 2011068944A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
tetraionic
optionally substituted
alkyl
alkynyl
Prior art date
Application number
PCT/US2010/058679
Other languages
English (en)
Inventor
Daniel W. Armstrong
Eranda Wanigasekara
Original Assignee
Sigma-Aldrich Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Aldrich Co. filed Critical Sigma-Aldrich Co.
Publication of WO2011068944A1 publication Critical patent/WO2011068944A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Definitions

  • the present invention relates to tetraionic liquid salts and their use in various chromatograph systems using electrospray ionization-mass spectrometry ("ESI-MS”) detection techniques.
  • ESI-MS electrospray ionization-mass spectrometry
  • Room temperature geminal dicationic liquids have been shown to possess superior physical properties in terms of thermal stability and volatility compared to traditional ionic liquids.
  • Polycationic liquid salts have been proposed for use as solvents and stationary phases, for example, in gas or liquid chromatography.
  • U.S. Publication Nos. 2006/0025598 and 2008/0027231 report high stability diionic liquid salts and use thereof and U.S. Publication No. 2008/0210858 reports high stability polyionic liquid salts and use thereof.
  • ICP-MS Inductively coupled plasma mass spectrometry
  • a tetraionic liquid salt comprises a tetraionic species corresponding in structure to Formula I: A-B-A-B-A-B-A
  • A is selected from the group consisting of optionally substituted protonated
  • each R is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, alkoxy, carbocyclyl, carbocyclylalkyl, heterocyclyl, heterocyclylalkyl and hydroxyalkyl;
  • each R group of protonated tertiary amine or phosphonium is optionally substituted with one or more substituents selected from the group consisting of Q-Q5 alkyl, alkenyl, alkynyl, alkoxy, carbocyclyl, carbocyclylalkyl, heterocyclyl, heterocyclylalkyl and hydroxyalkyl;
  • B is a divalent fragment composed of a chain of one or more moieties selected from the group consisting of C 3 -C 2 o-alkylene, C 2 -C 2 o-alkenylene, and C 2 -C 2 o-alkynylene;
  • C 3 -C 2 o-alkylene, C 2 -C 2 o-alkenylene, and C 2 -C 2 o-alkynylene optionally contain in the chain one or more heteroatoms selected from the group consisting of O, N, S and Si;
  • a further tetraionic liquid salt comprises a tetraionic species corresponding in structure to
  • a solvent comprising at least one tetraionic liquid salt comprising a tetraionic species of Formula I or Formula II, as defined herein.
  • a method of detecting at least one anion comprising using at least one tetraionic liquid salt comprising a tetraionic species corresponding in structure to Formula I or Formula II, as defined herein.
  • a device useful in chemical separation or analysis comprising a solid support and at least one tetraionic species adsorbed, absorbed or immobilized thereon corresponding in structure to Formula I or Formula II, as defined herein.
  • a method of separating one chemical from a mixture of chemicals comprising the steps of providing a mixture of at least one first chemical and at least one second chemical, exposing said mixture to at least one solid support including at least one tetraionic species adsorbed, absorbed or immobilized thereon corresponding in structure to Formula I or Formula II, as defined herein.
  • Figure 1 shows structures, names and masses of trivalent anions used herein.
  • Figure 2 shows examples of structures of tetraionic species of Formula I.
  • Figure 3 shows examples of structures of tetraionic species of Formula II.
  • Figure 4 shows examples of tricationic ion pairing agents.
  • ammonium refers to a positively charged polyatomic cation of the chemical formula , wherein the R groups are individually H or an organic radical group. Ammonium also embraces positively charged or protonated substituted amines (such as protonated tertiary amine). An "optionally substituted ammonium” is an ammonium wherein the organic radical group, R, is optionally substituted with other organic radical groups.
  • protonated tertiary amine refers to a positively charged polyatomic
  • R groups are organic radical groups.
  • R is optionally substituted protonated tertiary amine
  • hos honium refers to a positively charged polyatomic ion with
  • the R group is H or an organic radical group.
  • carbocyclyl (alone or in combination with another term(s)) means a saturated cyclic (i.e., “cycloalkyl"), partially saturated cyclic (i.e., “cycloalkenyl”), or completely unsaturated (i.e., "aryl”) hydrocarbyl substituent containing from 3 to 14 carbon ring atoms ("ring atoms” are the atoms bound together to form the ring or rings of a cyclic substituent).
  • a carbocyclyl may be a single ring (monocyclic) or polycyclic ring structure.
  • a carbocyclyl may be a single ring structure, which typically contains from 3 to 7 ring atoms, more typically from 3 to 6 ring atoms, and even more typically 5 to 6 ring atoms.
  • Examples of such single-ring carbocyclyls include cyclopropyl (cyclopropanyl), cyclobutyl (cyclobutanyl), cyclopentyl (cyclopentanyl), cyclopentenyl, cyclopentadienyl, cyclohexyl (cyclohexanyl), cyclohexenyl, cyclohexadienyl, and phenyl.
  • a carbocyclyl may alternatively be polycyclic or contain more than one ring.
  • polycyclic carbocyclyls include bridged, fused, spirocyclic, and isolated carbocyclyls.
  • a spirocyclic carbocyclyl one atom is common to two different rings.
  • An example of a spirocyclic carbocyclyl is spiropentanyl.
  • a bridged carbocyclyl the rings share at least two common non-adjacent atoms.
  • bridged carbocyclyls include bicyclo[2.2.1]heptanyl, bicyclo[2.2.1]hept-2-enyl, and adamantanyl.
  • a fused- ring carbocyclyl system multiple rings may be fused together, such that two rings share one common bond.
  • two- or three-fused ring carbocyclyls include naphthalenyl, tetrahydronaphthalenyl (tetralinyl), indenyl, indanyl (dihydroindenyl), anthracenyl, phenanthrenyl, and decalinyl.
  • the rings are separate and independent, as they do not share any common atoms, but a linker exists between the rings.
  • Carbocyclyl encompasses protonated carbocyclyls, such as
  • heterocyclyl (alone or in combination with another term(s)) means a saturated (i.e., “heterocycloalkyl"), partially saturated (i.e., “heterocycloalkenyl”), or completely unsaturated (i.e., "heteroaryl”) ring structure containing a total of 3 to 14 ring atoms. At least one of the ring atoms is a heteroatom (i.e., N, P, As, O, S and Si), with the remaining ring atoms being independently selected from the group consisting of carbon, oxygen, nitrogen, and sulfur.
  • a heterocyclyl may be a single -ring (monocyclic) or polycyclic ring structure.
  • heterocyclyl encompasses protonated heterocyclyls such as pyridinium, pyridazinium, pyrimidinium, pyrazinium, imidazolium, pyrazolium, thiazolium, oxazolium and triazolium.
  • a heterocyclyl may be a single ring, which typically contains from 3 to 7 ring atoms, more typically from 3 to 6 ring atoms, and even more typically 5 to 6 ring atoms.
  • single-ring heterocyclyls include furanyl, dihydrofuranyl, tetrahydrofuranyl, thiophenyl (thiofuranyl), dihydrothiophenyl, tetrahydrothiophenyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, imidazolyl, imidazolinyl, imidazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, triazolyl, tetrazolyl, oxazolyl, oxazolidinyl, isoxazolidinyl, isoxazolidinyl, isoxazolidinyl, isoxazolyl, thiazolyl, isothi
  • a heterocyclyl may alternatively be polycyclic or contain more than one ring.
  • polycyclic heterocyclyls include bridged, fused, and spirocyclic heterocyclyls.
  • a spirocyclic heterocyclyl one atom is common to two different rings.
  • a bridged heterocyclyl the rings share at least two common non-adjacent atoms.
  • a fused-ring heterocyclyl multiple rings may be fused together, such that two rings share one common bond.
  • fused ring heterocyclyls containing two or three rings examples include indolizinyl, pyranopyrrolyl, 4H-quinolizinyl, purinyl, naphthyridinyl, pyridopyridinyl (including pyrido[3,2-b]-pyridinyl or pyrido[3,4-b]-pyridinyl), and pteridinyl.
  • fused-ring heterocyclyls include benzofused heterocyclyls, such as indolyl, isoindolyl (isobenzazolyl, pseudoisoindolyl), indoleninyl (pseudoindalyl), isoindazolyl (benzpyrazolyl), benzazinyl (including quinolinyl (1- benzazinyl) or isoquinolinyl (2-benzazinyl)), phthalazinyl, quinoxalinyl, quinazolinyl, benzodiazinyl (including cinnolinyl (1,2-benzodiazinyl) or quinazolinyl (1,3- benzodiazinyl)), benzopyranyl (including chromanyl or isochromanyl), benzoxazinyl (including 1,2,3-benzoxazinyl, 1,2,4-benzoxazinyl, or 1,3,4-benzoxazine
  • alkyl refers to an alkane-derived radical containing from 1 to 20 carbon atoms.
  • Alkyl includes straight chain alkyl, branched alkyl and cycloalkyl. Straight chain or branched alkyl groups contain from 1-15 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, i-butyl, and the like.
  • Alkyl also includes straight chain or branched alkyl groups that contain or are interrupted by one or more cycloalkyl portions.
  • alkyl group is attached at any available point to produce a stable compound.
  • alkyl is also meant to encompass a fully substituted carbon.
  • alkenyl refers to a straight or branched hydrocarbyl group with at least one site of unsaturation, i.e. a carbon-carbon, sp2 double bond. In an embodiment, alkenyl has from 2 to 15 carbon atoms. In some embodiments, alkenyl is a C2-C10 alkenyl group or a C2-C6 alkenyl group. Examples of alkenyl groups include, but are not limited to, ethylene or vinyl (-CH CH2), allyl (-CH2CH CH2), cyclopentenyl (-C5H7), and 5-hexenyl (-CH2CH2CH2CH2CH CH2).
  • alkynyl refers to a straight or branched carbon- chain group with at least one site of unsaturation, i.e. a carbon-carbon, sp triple bond. In an embodiment, alkynyl has from 2 to 15 carbon atoms. In some embodiments, alkynyl is a C2-C 10 alkynyl group or a C 2 -C 6 alkynyl group. Examples of alkynyl groups include acetylenic (-C ⁇ CH) and propargyl (-CH2C ⁇ CH).
  • alkylene refers to a divalent alkane-derived radical containing 1 to 20 carbon atoms, such as 1 to 15 carbon atoms, 3 to 20 carbon atoms, 3 to 12 carbon atoms, or 3 to 9 carbon atoms, from which two hydrogen atoms are taken from the same carbon atom or from different carbon atoms.
  • alkylene include, but are not limited to, methylene — CH 2 — , ethylene— CH 2 CH 2 — , and the like.
  • amino (alone or in combination with another term(s)) means " NH 2 .
  • amino is meant to encompass a "mono substituted amino” (alone or in combination with another term(s)) wherein one of the hydrogen radicals is replaced by a non-hydrogen substituent; and a "disubstituted amino" (alone or in combination with another term(s)) wherein both of the hydrogen atoms are replaced by non-hydrogen substituents, which may be identical or different.
  • alkoxy (alone or in combination with another term(s)) means an alkylether, i.e., -O-alkyl.
  • alkylether i.e., -O-alkyl.
  • substituents include methoxy (-O-CH 3 ), ethoxy, rc-propoxy, isopropoxy, rc-butoxy, isobutoxy, sec-butoxy, ieri-butoxy, and the like.
  • carrier alkylalkyl refers to the group— Z-carbocyclyl where Z is lower alkylene or substituted lower alkylene group.
  • heterocyclylalkyl refers to the group— Z-heterocyclyl where Z is lower alkylene or substituted lower alkylene group.
  • tetraionic salt is used to describe a salt molecule, although, as the context suggests, it may be used synonymously with “tetraionic liquid” (“TIL”) and “tetraionic liquid salt” (“TILS").
  • a “tetraionic liquid” or “tetraionic liquid salt” in accordance with the present invention is a liquid comprised of a tetraionic salt. Thus, sufficient tetraionic salt molecules are present such that they exist in liquid form at the temperatures indicated herein.
  • a TIL is either (1) a tetracationic liquid or (2) a tetraanionic liquid.
  • a "tetracationic liquid salt” or “tetracationic liquid”, as mentioned above, is either a salt molecule or a liquid comprised of tetracationic salt(s), wherein the tetra cationic salt(s) is formed between a tetracationic species and one or more counter-anions of equal, greater than, or less than opposite charge.
  • This invention is directed, in part, to a TILS comprising a tetraionic species and at least one counterion.
  • the TILS corresponds in structure to Formula I:
  • A is selected from the group consisting of optionally substituted protonated
  • each R is independently selected from the group consisting of H, alkyl, alkenyl, alkynyl, alkoxy, carbocyclyl, carbocyclylalkyl, heterocyclyl, heterocyclylalkyl and hydroxyalkyl;
  • each R group of protonated tertiary amine or phosphonium is optionally substituted with one or more substituents selected from the group consisting of Q-Q5 alkyl, alkenyl, alkynyl, alkoxy, carbocyclyl, carbocyclylalkyl, heterocyclyl, heterocyclylalkyl and hydroxyalkyl;
  • B is a divalent fragment composed of a chain of one or more moieties selected from the group consisting of C3-C 2 o-alkylene, C 2 -C 2 o-alkenylene, and C 2 -C 20 - alkynylene;
  • C3-C 2 o-alkylene, C 2 -C 2 o-alkenylene, and C 2 -C 2 o-alkynylene optionally contain in the chain one or more heteroatoms selected from the group consisting of O, N, S and Si;
  • B is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, alkoxy, and halo.
  • R is alkyl, such as methyl, ethyl, propyl, isopropyl, n- butyl, sec-butyl, isobutyl, or i-butyl.
  • R is selected from the group consisting of methyl, phenyl, rc-butyl and propyl. R may be substituted with an organic radical group.
  • Each B is a bridging group. Each B may, where present, be the same or different. In some embodiments, B is selected from the group consisting of propylene, butylene, hexylene, decylene, and dodecylene.
  • Formula is individually selected from the group consisting of phosphonium of formula or , and imidazolium
  • each R is independently alkyl or carbocyclyl.
  • each R is independently selected from the group consisting of methyl, ethyl, propyl, isopropyl, zi-butyl, sec-butyl, isobutyl, i-butyl and phenyl
  • B is independently selected from the group consisting of propylene, butylene, hexylene, decylene, and dodecylene.
  • each R is selected from the group consisting of methyl, phenyl, n-butyl, isopropyl and propyl.
  • each R is independently alkyl or carbocyclyl.
  • each R is independently selected from the group consisting of methyl, ethyl, propyl, isopropyl, /i-butyl, sec-butyl, isobutyl, i-butyl and phenyl
  • each B is independently selected from the group consisting of propylene, butylene, hexylene, decylene, and dodecylene.
  • each R is independently selected from the group consisting of methyl, phenyl, n-butyl, isopropyl and propyl.
  • each R is independently alkyl or carbocyclyl.
  • each R is independently selected from the group consisting of methyl, ethyl, propyl, isopropyl, /i-butyl, sec-butyl, isobutyl, i-butyl and phenyl
  • each B is independently selected from the group consisting of propylene, butylene, hexylene, decylene, and dodecylene.
  • each R is selected from the group consisting of methyl, phenyl, n-butyl, isopropyl and propyl.
  • Non-limiting examples of such compounds include those selected from the following structure, where each R is independently selected from the group consisting of methyl and phenyl; and each B is independently selected from the group consisting of propylene, butylene, hexylene and decylene.
  • A is optionally substituted tertiary amine and B is C 3 -C 12 alkylene.
  • each R is independently alkyl or carbocyclyl.
  • each R is independently selected from the group consisting of methyl, ethyl, propyl, isopropyl, /i-butyl, sec-butyl, isobutyl, i-butyl and phenyl
  • each B is independently selected from the group consisting of propylene, butylene, hexylene, decylene, and dodecylene.
  • each R is selected from the group consisting of methyl, phenyl, n-butyl, isopropyl and propyl.
  • the TILS corresponds in structure to Formula II:
  • A is selected from the group consisting of phosphonium of formula
  • each R is independently selected from the group consisting of alkyl, alkenyl, alkynyl, carbocyclyl, carbocyclylalkyl, heterocyclyl, heterocyclylalkyl, and hydroxyalkyl;
  • Each B is a bridging group. Each B may, where present, be the same or different.
  • B is a divalent fragment composed of a chain of one or more moieties selected from the group consisting of CrC ⁇ -alkylene, C 2 -C 2 o-alkenylene, C 2 -C 2 o-alkynylene, (- CH 2 -carbocyclyl-CH 2 -), and (-CH 2 -carbocyclyl-); wherein Q-C ⁇ -alkylene, C 2 -C 20 - alkenylene, and C 2 -C 2 o-alkynylene optionally contain in the chain one or more heteroatoms selected from the group consisting of O, N, S and Si; wherein B is optionally substituted with one or more substituents selected from the group consisting of alkyl, alkenyl, alkynyl, alkoxy, and halo.
  • R is phenyl
  • B is selected from the group consisting of propylene, butylene, and hexylene.
  • Non-limiting examples of such compounds include those found in Figure 3.
  • Tetraionic species of the present invention can be classified as symmetric or unsymmetric.
  • the tetraionic species are symmetric.
  • symmetric it is meant that the tetraionic species possess symmetric bridging groups B and identical ionic groups A.
  • the tetraionic species can also be center- symmetric.
  • center- symmetric it is meant that the tetraionic species possess a symmetric central bridging group B regardless whether the ionic groups A are identical.
  • the tetraionic species are unsymmetric.
  • unsymmetric it is meant that the monoionic groups A are structurally different, or that the bridging groups B are unsymmetric, or that the monoionic groups conjugate to the central group in such a manner that the polyionic species is not symmetric.
  • the invention encompasses unsymmetric tetraionic species due to any compositional and/or structural arrangement.
  • an unsymmetric tetraionic species of the invention contains different monoionic groups.
  • A can be different cations such as substituted or unsubstituted, saturated or unsaturated, straight or branched aliphatic chain, cyclic group, aromatic group, protonated tertiary amine, phosphonium or imidazolium group.
  • the unsymmetric tetraionic salts of the invention can be used in a substantially pure form in any of the applications, e.g., the applications disclosed in this application.
  • tetraionic salts which do not have identical monoionic groups or which include an unsymmetric central group generally have lower melting temperatures, and advantage for "liquid" salts.
  • the higher the degree of internal structural dissimilarity as compared to corresponding symmetric polyionic salts generally the lower the melting temperatures will result as compared to those of the corresponding symmetric polyionic salts.
  • the trend can be thought of as a continuum from a symmetric molecule on the one end and a group with all different counterions, all different ions, and different substituents on the other.
  • the former would be expected to have the highest melting point and the latter the relatively lowest.
  • a specific counterion might have a greater effect on decreasing melting point than the use of other different ions.
  • the unsymmetric tetraionic salts of the invention may also be advantageous for uses as solvents.
  • a tetraionic species having four different A groups offers four sets of possible interactions with other molecules in the solution as compared to only one set in the case of a symmetric tetraionic species.
  • the more unsymmetric the more the variety of interactions that can result.
  • the invention provides a use of a TIL of a substantially pure "unsymmetric" tetraionic salt as describe herein as a solvent.
  • the unsymmetric TILSs of the invention can be used in a substantially pure form in any of the applications, e.g., the applications disclosed in this application.
  • the unsymmetric tetraionic salts of the invention can also be used in combination with any of the symmetric tetraionic salts as a mixture.
  • the invention provides a TIL of a substantially pure unsymmetric tetraionic salt as described above.
  • the invention provides a TIL comprising at least one of the unsymmetric polyionic salts as described above and at least one symmetric tetraionic salt of the invention.
  • a person skilled in the art would be able to determine the proportion of the symmetric and unsymmetric TILSs when used as a mixture according to the particular application.
  • the TILs of the present invention are generally salts, although they may exist as ions (+3, -3, +4, -4, etc.) in certain circumstances. Thus, in most instances, each ion has a counterion, one for each anion or cation. Charge should be preserved in most cases. In the case of a polyanionic ionic liquid, cations are required and in the case of a polycationic ionic liquid, anions are required. The choice of anion can have an effect of the properties of the resulting compound and its utility as a solvent.
  • salt-forming ions will be referred to as counterions herein.
  • Anionic counterions can be selected from any of the polyanionic molecules discussed herein useful in the creation of polyanionic ionic liquids. These would include dicarboxylates, disulfonates and disulfates. The corresponding monoionic compounds may also be used including carboxylates, sulfonates, sulfates, phosphonates, and hydroxide. Halogen and halogen-containing compounds that may be used include, without limitation, triflate, NTf 2 ⁇ , PF 6 ⁇ , BF 4 ⁇ , and the like. The counterions should be selected such that the polyionic liquids have good thermal and/or chemical stability and have a solid/liquid transformation temperature and/or a liquid range as described herein.
  • the ionic groups of the present invention can be substituted or unsubstituted. They may be substituted with halogens, with alkoxy groups, with aliphatic, aromatic or cyclic groups, with nitrogen-containing species, with silicon-containing species, with oxygen-containing species, and with sulfur-containing species.
  • the degree of substitution and the selection of substituents can influence the properties of the resulting material as previously described in discussing the nature of the bridge or chain. Thus, care should be taken to ensure that excessive steric hindrance and excessive molecular weight are avoided, that resulting materials do not lose their overall flexibility and that nothing will interfere with the ionic nature of the two ionic species.
  • the counterions are anions which, without limitation, include hydroxide, halogens, mono-carboxylates, mono-sulfonates, mono-sulfates, NTf 2 ⁇ , BF 4 " , trifilates, or PF 6 " , as well as molecules having anionic groups each selected from, without limitation, carboxylate, sulfate or sulfonate groups.
  • the at least one counter-anion of the TILS is independently selected from the group consisting of citrate, sulfanilic acid azochromotrop, trimetaphosphate, nitrilotriacetic tricarboxylate, phosphate, tartrazine, hexanitrocobaltate, pyranine, indigotrisulfonate, hexachlororhodate, tris(2,4-dimethyl-5-sulfophenyl)-phosphine, chromium oxalate, oxalomalic tricarboxylate, phosphoformate, orthovanadate, hexacyanocobaltate, 8- methoxypyrene-l,3,6-trisulfonate, 8-octanoyloxypyrene-l,3,6-trisulfonate, and 8- nonanoyloxypyrene-l,3,6-trisulfonate.
  • counters sulfanilic
  • Ri is selected from the group consisting of hydrogen, alkyl, hydroxyalkyl, carbocyclyl, heterocyclyl, halo, alkoxy, hydroxyl, alkylcarbonyl, alkylcarbonylalkylene, hydroxycarbonyl,
  • Xi is CrCio-alkylene
  • X 2 is selected from the group consisting of hydrogen, alkyl, alkoxy, amino and hydroxy;
  • Yi is selected from the group consisting of hydrogen and alkyl
  • Y 2 is CrCio-alkylene.
  • Counterions can be monoionic, diionic or polyionic ions, or a mixture thereof. They can be the same or different so long as they all have the same type of charge (positive or negative) and the total charge is m.
  • a polyionic liquid can be a mixture of a polycationic liquid and a polyaninoic liquid.
  • the tetracationic species is selected from the group consisting of:
  • the TILS comprises a tetraionic species shown in Figures 2 and 3.
  • the TILS comprises a tetraionic species corresponding in structure to
  • This invention is also directed to solvents comprising one or more TILSs in accordance with the invention.
  • the solvent comprises at least one tetraionic liquid salt comprising a tetraionic species of Formula I or Formula II, as defined herein.
  • the solvent comprises one of the tetraionic species set forth in Figures 2 and 3.
  • the solvent comprises more than one tetraionic species set forth in Figures 2 and 3.
  • one or more TILSs can be used as a solvent for dissolution, suspension or dispersion of solids or liquid mixed therewith or as a reaction solvent for chemical reactions. Both are intended by the term solvent.
  • the TILSs of the present invention can be used in pure or in substantially pure form as carriers or as solvents. "Substantially" in this context means no more than about 10% of undesirable impurities. Such impurities can be other undesired tetraionic salts, reaction by-products, contaminants or the like as the context suggests. In an intended mixture of two or more TILSs, neither would be considered an impurity. Because they are non-volatile and stable, they can be recovered and recycled and pose few of the disadvantages of volatile organic solvents. Because of their stability over a wide liquid range they can be used in chemical synthesis that requires both heating and cooling. Indeed, these solvents may accommodate all of the multiple reaction steps of certain chemical syntheses.
  • these TILs may be used in solvent systems with co- solvents and gradient solvents and these solvents can include, without limitation, chiral ionic liquids, chiral non-ionic liquids, volatile organic solvents, non-volatile organic solvents, inorganic solvents, water, oils, etc. It is also possible to prepare solutions, suspensions, emulsions, colloids, gels and dispersions using the TILs. Tetraionic salts in accordance with the invention may be used in any mixture, including different polycations, different polyanions and mixtures of polycations and polyanions. In addition, one or more of the TILSs of the invention may be mixed with diionic liquid salts as described in U.S. Patent Publication No. 2006/0025598 and 2008/0027231 or triionic liquid salts as described in U.S. Patent Publication No. 2008/0210858, the text of which are hereby incorporated by reference.
  • Polymers may include the polyionic liquid salts within the backbone or as pendant groups and they may be cross-linked or non-cross-linked.
  • a method of detecting at least one anion comprising using at least one TILS comprising a tetraionic species corresponding in structure to Formula I or Formula II as defined herein.
  • ESI-MS is used to detect the at least one anion.
  • ESI-MS is carried out in the positive ion mode.
  • the TILS pairs with a single anion yielding a positively charged complex.
  • ESI-MS provides an alternative approach for the analysis of anions and, in particular, complex ions can be detected in their native forms without decomposition. Coupled with separation methods, ESI-MS is capable of detecting most ionic species. However, as powerful as ESI-MS is in the positive mode, it can suffer from lower sensitivity in the negative mode. One cause for the decrease in sensitivity in the negative mode is the prevalence of corona discharge sometimes leading to arcing events. This phenomenon results in an unstable Taylor cone and higher background noise leading to poorer LODs. Studies have shown that corona discharge in the negative mode can be suppressed by using halogenated solvents or alcohols with longer alkyl chains such as propanol, 2-propanol, and butanol.
  • ESI-MS may be used alone or coupled with a separation method.
  • separation techniques include, without limitation, LC, high performance liquid chromatography ("HPLC”), ion chromatography, ion- exchange chromatography, solid phase extraction (“SPE”), solid phase microextraction (“SPME”), task-specific SPME (“TS-SPME”) and SPME Matrix- Assisted Laser Desorption/Ionization (“MALDI”).
  • HPLC high performance liquid chromatography
  • SPE solid phase extraction
  • SPME solid phase microextraction
  • TS-SPME task-specific SPME
  • MALDI SPME Matrix- Assisted Laser Desorption/Ionization
  • MALDI SPME Matrix- Assisted Laser Desorption/Ionization
  • the TILS is added to a carrier flow solvent following the separation technique.
  • one or more TILSs in accordance with the present invention can be used in a detection technique such as, but not limited to, Direct Analysis in Real Time (“DART") and / or Desorption Electrospray Ionization ("DESI").
  • DART and DESI may be used alone, together, or coupled with a separation method. Examples of such separation techniques include, without limitation, LC, HPLC, ion chromatography, ion-exchange chromatography, SPE, SPME, TS-SPME and SPME MALDI.
  • the method includes selecting a tetraionic species that has a desired composition and structure, e.g., a desired charged group structure and a desired mass, or a combination thereof.
  • the charged groups in the tetraionic species can be selected based on the composition and structure of the charged molecule to be detected.
  • the tetraionic species is specific for the charged molecule to be detected.
  • the charged group of the tetraionic species is such that it binds strongly with the charged molecule to be detected. More preferably, the charged groups of the tetraionic species is such that it does not bind strongly with other charged molecules in the sample.
  • the detection of dianions through complexation with tricationic pairing agents is provided. It has been determined that benzylimidazolium and tripropylphosphonium are better cationic moieties and the reagents of flexible linear structure generally work better than rigid trigonal trications.
  • a device useful in chemical separation or analysis comprising: a solid support and at least one tetraionic species adsorbed, absorbed or immobilized thereon corresponding in structure to Formula I or Formula II as defined herein.
  • a tetraionic species described herein such as the tetraionic species shown in Figures 2 and 3, is suitable for use in chemical separation.
  • Such a device is particularly useful for chemical separations.
  • an immobilized TILS including one or more TILSs (with or without monoionic materials) as stationary phases, particularly in gas chromatography ("GC").
  • TILSs with or without monoionic materials
  • GC gas chromatography
  • These stationary phases are highly selective, highly stable, and highly resistant to temperature degradation.
  • These materials can be non-cross-linked (which often means that they are absorbed or adsorbed on a solid support or column), can be "partially" cross-linked or "more highly” cross-linked (which often means that they are "immobilized” on a solid support or column) and can be composed of a mixture of TILSs and tetraionic material and/or dicationic, tricationic, or monocationic materials or can be made completely of TILSs in accordance with the present invention.
  • the presence of unsaturated groups facilitates cross-linking and/or immobilization.
  • the TILS(s) used may be saturated, unsaturated or a mixture of both. It should be understood, however, particularly if some amount of unsaturated TILS(s) is used, and especially where heat is used to fix the stationary phase, or the stationary phase is heated during use, as in GC, some degree of cross-linking is possible.
  • the stationary phases are made from a tetraionic species which is chiral and optically enhanced.
  • cross-linking and/or immobilization of the TILS in a column as a stationary phase, or to a solid support for SPE, SPME, TS-SPME, SPME/MALDI, ion chromatography, ion exchange chromatography, headspace analysis or other analytical or separation technique may not affect the selectivity of the stationary phase, thereby preserving its dual nature retention behavior.
  • stationary phases for GC and, in particular, capillary GC are one particular aspect of the present invention
  • the TILS(s), either alone or in combination with monoionic, diionic, and/or triionic liquid salt(s) can be used as a stationary phase in other forms of chromatography including, for example, LC and HPLC.
  • the stationary phases, solid supports and columns themselves and the use of columns and solid supports containing these stationary phases in chromatography, and other analytical or separation techniques are contemplated as specific aspects of the invention.
  • a TILS can be coated on a capillary (or solid support) and optionally, subsequently polymerized and/or cross-linked by, for example, two general methods.
  • the ionic liquid is coated via the static coating method at 40°C using coating solution concentrations ranging from 0.15-0.45% (w/w) using solutions of methylene chloride, acetone, ethyl acetate, pentane, chloroform, methanol, or mixtures thereof.
  • the column is purged with helium and baked up to 100°C.
  • naphthalene other molecules such as n- hydrocarbons or Grob Test Mixture can also be used for this purpose
  • the efficiency of naphthalene is then evaluated to examine the coating efficiency of the monomer ionic liquid stationary phase. If efficiency is deemed sufficient, the column is then flushed with vapors of azo-ieri-butane, a free radical initiator, at room temperature. After flushing with the vapors, the column is then fused at both ends and heated in an oven using a temperature gradient up to 200°C for 5 hours. The column is gradually cooled and then re-opened at both ends, and purged with helium gas. After purging with helium gas overnight, the column is then heated and conditioned up to 200°C.
  • azo-ieri-butane a free radical initiator
  • Immobilized in the context of the invention means covalently or ionically bound to a support or to another ionic liquid (including TILSs) or both. This is to be compared with ionic liquids which may be absorbed or adsorbed on a solid support. Solid supports in these particular instances are intended to include columns (e.g., the walls of the columns).
  • the second method involves adding a percentage of the TILS monomer weight of 2,2'-azobisisobutyronitrile ("AIBN") free radical initiator to the coating solution of the monomer.
  • AIBN 2,2'-azobisisobutyronitrile
  • the capillary column is then filled with this solution and coated via the static coating method. After coating, the capillary column is then sealed at both ends and placed in an oven and conditioned up to 200°C for 5 hours. The column is gradually cooled and then re-opened at both ends, and purged with helium gas. After purging with helium gas overnight, the column is then heated and conditioned up to 200°C. After conditioning, the column efficiency is then examined using naphthalene at 100°C and the stationary phase coated layer examined under a microscope.
  • AIBN 2,2'-azobisisobutyronitrile
  • a process which includes the free radical reaction of ionic liquid monomers to provide a more durable and robust stationary phase, as well as the cross-linked and/or immobilized stationary phases and the columns that include same.
  • ionic liquid stationary phase By partially cross-linking the ionic liquid stationary phase using a small percentage of free radical initiator, high efficiency capillary columns are produced that are able to endure high temperatures with little column bleed. It was found that low to moderate temperature separations (30°C-280°C) can be carried out with high selectivity and efficiency using special partially cross-linked ionic liquid stationary phase mixtures. These stationary phases retain their "gelatinous", “semi liquid", or "amorphous" state.
  • a mixed stationary phase (“MSP”) is provided.
  • the MSP comprises at least one TILS of the invention and stationary phase material such as, but not limited to, polysiloxanes, polyethylene glycols (“PEGs”), methylpolysiloxanes, phenyl substituted methylpolysiloxane, nitrile substituted methylpolysiloxane and carbowax.
  • MSPs can be used as a stationary phase in chromatography such as GC, LC and HPLC as well as in SPE and SPME.
  • the MSPs can be non-cross-linked (e.g., absorbed or adsorbed on a solid support or column), can be "partially" cross-linked or "more highly” cross-linked (i.e., immobilized on a solid support or column).
  • the TILS may also be cross-linked or otherwise reacted with the stationary phase material or merely mixed therewith.
  • the ratio of the TILS and the stationary phase material in the MSP is from about 1 :9 (i.e., about 10% of TILS and 90% of traditional stationary phase material) to about 9: 1 (i.e. , about 90% of TILS and about 10% of stationary phase material), about 1 :3 (i.e., about 25% of TILS and about 75% of stationary phase material) to about 3: 1 (i.e.
  • Chromatography employing a MSP may perform better, e.g., having higher selectivity, than chromatography employing TILS(s) or the stationary phase material alone.
  • the invention also provides methods of preparing MSPs, solid supports and/or columns containing same, the MSPs, solid supports, syringes, tubes, pipettes tips, needles, vials, and columns themselves, and the use of columns and solid supports containing such MSPs in chromatography and other analytical or separation techniques such as those described elsewhere herein.
  • the invention includes not only the use of TILSs, but also solid supports to which the TILSs are absorbed, adsorbed or immobilized as well as sampling devices such as, for example, pipettes, automatic pipettes, syringes, microsyringes and the like incorporating TILSs, which can be used in such analytical and separation techniques.
  • Solid supports include, without limitation, mixed beds of particles coated with TILSs. These may be used as chromatographic media or for SPE, SPME, SPME/MALDI and ion exchange analysis.
  • Particles may be composed of, for example, silica, carbons, composite particles, metal particles (zirconia, titania, etc.), as well as functionalized particles, etc., contained in, for example, tubes, pipettes tips, needles, vials, and other common containers.
  • the device comprises a syringe, a hollow needle, a plunger, and the solid support being attached to the syringe.
  • Another embodiment is a device useful in chemical separation or analysis comprising: a solid support and one or more TILSs, of, for example, Figures 2 and 3, adsorbed, absorbed or immobilized thereon.
  • the device may be a column used in HPLC, GC or supercritical fluid chromatography ("SFC") wherein the solid support is either packed in a chromatographic column or a capillary column useful within GC.
  • the device may also be a syringe having a hollow needle defining an inner space, the needle being disposed at an end of a barrel and a plunger disposed within the barrel, the solid support being attached, mounted, affixed, irremovable or removably attached (collectively "attached"), to the syringe such that it may be retracted into the inner space of the needle when the plunger is retracted from the barrel and exposed from within the needle when the plunger is inserted into the barrel.
  • the syringe is a microsyringe.
  • the one or more TILSs used in these devices also include monoionic materials which may be simply mixed therewith or which may be cross-linked to the TILSs of the invention. These may be absorbed, adsorbed or immobilized on the solid support. When immobilized, it is preferred that these ionic species include unsaturated groups.
  • a method of separating one chemical from a mixture of chemicals comprising the steps of: providing a mixture of at least one first and at least one second chemical, exposing said mixture to at least one solid support including at least one tetraionic species adsorbed, absorbed or immobilized thereon of Formula I or Formula II as defined herein.
  • Any tetraionic species described herein, such as the tetraionic species shown in Figures 2 and 3, is suitable for use in separating one chemical from a mixture of chemicals.
  • one or more TILSs in accordance with the present invention can be used in analytical and separation technologies such as, but not limited to, LC, HPLC, SPE, SPME, TS-SPME, and mass spectrometry known as SPME/MALDI, as well as ion exchange and headspace analysis.
  • analytical and separation technologies such as, but not limited to, LC, HPLC, SPE, SPME, TS-SPME, and mass spectrometry known as SPME/MALDI, as well as ion exchange and headspace analysis.
  • Retaining in this context does not mean permanently. Separation can occur in a syringe device by removal of the device from the sample or ejection of the second chemical.
  • the first chemical will be absorbed or adsorbed at a different rate than the second chemical, which may be at a greater rate or a lower rate, thus resulting in separation.
  • Both are moved through the column by a mobile phase, which can be a liquid or a gas and their interaction with the stationary phase (the ionic liquid materials on the solid support) at different rates causes separation. This is what is meant by "retention" in the context of chromatography.
  • the first chemical is bound to the stationary phase while the second chemical is not and is carried through the column by the mobile phase until it elutes.
  • the first chemical can be eluted or removed separately and this is also embraced by the word "retained.”
  • one or more TILSs can be used in SPE.
  • SPE a sample contains an impurity or some other compound or analyte to be separated, identified and/or quantified.
  • This sample can be placed into a container in which one or more TILSs of the present invention can be present, and more broadly, TILSs in an immobilized form.
  • Ionic liquid materials can be bound (immobilized) to the walls of the container, adsorbed, or absorbed onto a bead or other structure so as to form a bead or other structure which may rest at the bottom of the container or be packed throughout the container much as a liquid chromatography column can be packed with stationary phase.
  • the TILS can be immobilized by cross-linking or an analogous immobilization reaction as described herein on some sort of other solid support such as a bead, particles and/or other chromatographic media used in chromatography as described previously. These beads can also be placed at the bottom of, or can fill a container, much as is a packed column used for liquid chromatography.
  • the solid support can be any structure placed anywhere within the container.
  • the container is actually a syringe where the TILS is affixed or disposed in one fashion or another at the base of the syringe, much as a filter.
  • the TILS is affixed or disposed in one fashion or another at the base of the syringe, much as a filter.
  • the sample liquid can be analyzed either for the presence of certain materials or the absence of the material retained by the TILS.
  • the retained materials can be removed (such as by placing the materials in a different solvent) or not removed, and analyzed by other means.
  • the same technique may be used in a preparative fashion and/or as a means of bulk purification as well.
  • one or more TILSs may be used in SPME.
  • a separation material in this case an ionic liquid or in particular a TILS in accordance with the present invention or ionic liquids mixed with adsorbents, particles and other chromatographic media
  • a fiber e.g., polydimethylsiloxane/ divinylbenzene (“PDMS/DVB”) fiber
  • PDMS/DVB polydimethylsiloxane/ divinylbenzene
  • some other solid support which is applied to the plunger as a coating or as a sheet generally attached to a plunger in a microsyringe such as usually used in GC.
  • a TILS of the invention can also be immobilized and attached directly without any separate solid support other than the plunger. This can be done using, for example, a film directly.
  • the plunger is depressed, exposing the fiber and the fiber is then dipped into the sample of interest.
  • the plunger can then be withdrawn to pull the fiber back into the barrel of the syringe, or at least the barrel of the needle for protection and transport.
  • the syringe can then be injected through the septum of a gas chromatograph or some other device and the fiber thereby inserted into the column by redepressing the plunger of the microsyringe.
  • the heat used in GC then volatilizes or otherwise drives the bound sample off where it is carried by the mobile phase through the GC column, allowing for separation and/or identification. It can also be eluted by a liquid mobile phase in an HPLC injector or unbuffered capillary electrophoresis. Immobilized TILS may also be used in conjunction with the coated stir bar technology, which is a higher capacity version of SPME. Some embodiments of this coated stir bar technology are sold under the trademark TWISTERTM.
  • SPME is a technique in which a small amount of extracting phase (in this case an ionic liquid and preferably a TILS in accordance with the present invention) is disposed on a solid support, which is then exposed to a sample for a period of time.
  • a partitioning equilibrium between a sample matrix and the extraction phase is reached.
  • a short time pre-equilibrium extraction is realized and the amount of analyte extracted is related to time.
  • Quantification can then be performed based on the timed accumulation of analysis in the coating.
  • in-tube approaches have also been demonstrated. In-tube approaches require the extracting phase to be coated on the inner wall of the capillary and the sample containing the analyte of interest is subject to the capillary and the analytes undergo partitioning to the extracting phase. Thus, material can be coated on the inner wall of a needle, for example, and the needle injected without the need for a separate solid support.
  • one or more TILSs can be immobilized by being bound or cross- linked to themselves and/or to a solid support as previously discussed in connection with manufacturing capillary GC columns. To do so, however, the species used should have at least one unsaturated group disposed to allow reaction resulting in immobilization.
  • SPME task-specific SPME
  • TS-SPME allows for the separation or removal, and therefore the detection of particular species. These can include, for example, mercury and cadmium, although the technique is equally applicable to other materials.
  • species can include, for example, mercury and cadmium, although the technique is equally applicable to other materials.
  • the concept is exactly the same as previously described with regard to SPME.
  • the TILS(s) used are further modified such that they will specifically interact with a particular species.
  • the first monocationic material can be coated, absorbed or adsorbed onto a fiber as previously discussed.
  • a TILS can also be absorbed or adsorbed in known fashion.
  • a particular sample can be suspended in a matrix that includes TILS(s).
  • This matrix can be loaded or immobilized on the fiber of an SPME syringe as described above and then injected into a mass spectrometer to practice a technique known as SPME/MALDI mass spectrometry.
  • the matrix is exposed to a UV laser. This causes the volatilization or release of the sample much as heat does in a GC. This allows the sample to enter mass spectrometer where it can be analyzed.
  • a Finnigan LXQ Thermo Fisher Scientific, San Jose, CA
  • ESI-MS was used for all of the analyses in this study.
  • the positive mode ESI-MS conditions were as follows: spray voltage, 3 kV; sheath gas flow, 37 arbitrary units ("AU"); auxiliary gas flow rate, 6 AU; capillary voltage, 11 V; capillary temperature, 350°C; tube lens voltage, 105 V.
  • SIM positive selective ion monitoring
  • the isolation widths were between 1 and 5, the normalized collision energy was 30, and the activation time was 30 ms.
  • Xcalibur and Tune Plus software were used to analyze data. The initial concentrations of anion stock solutions were 1 mg/mL.
  • Sulfanilic acid, azochromotrop, tartrazine, indigotrisulfonate, 8-methoxypyrene- 1 ,3,6-trisulfonate, 8-octanoyloxypyrene- 1 ,3,6- trisulfonate, pyranine and 8-nonanoyloxypyrene-l,3,6-trisulfonate are dyes.
  • tartrazine is a commonly used food pigment and is also found to be associated with a variety of children's behavioral changes when ingested.
  • tetracations have one more charged moiety and one more carbon linkage chain than the linear trications, more variations in the structures can be made, such as the length of the middle and side carbon chain linkages, as well as, the arrangement of different cationic moieties at the middle and end. All these linear tetracations can be divided to three groups: pure imidazolium based, pure phosphonium based, and imidazolium and phosphonium mixed tetracations.
  • center carbon chain length C 4 , C 6 , and Cio
  • side carbon chain length C 3 , C 6 , and C 10
  • center cation moieties imidazolium, diisopropyl phosphonium, diphenyl phosphonium
  • terminal groups methyl imidazolium, benzyl imidazolium, triphenylphosphonium and tripropylphosphonium
  • the LODs for the trivalent anions in the negative mode were determined and listed in Table 1. It should be noted that most trivalent anions do not exist in their -3 charged state in aqueous solution. They can either be singly protonated to become a divalent anion or doubly protonated to a singly charged ion. Therefore, the LODs in the negative mode were determined from the base peak. For example, all the three charged states (-1, -2, -3) of trimetaphosphate can be seen in the negative mode, and the LOD was obtained by monitoring only the -3 peak as it had the best signal to noise ratio.
  • the LODs for the rest of the anions range from 250 pg (XI) to 20ng (V).
  • Anions containing sulfonate groups generally had lower LODs while metal containing anions had relatively high LODs.
  • the LODs for eight anions (II, VIII, IX, XI, XV, XVII, XVII, XIX) were determined based on their singly protonated form, four anions (I, IV, V, XII) were determined as doubly protonated (-2) species, and only one anion (III) from the unprotonated (-3) species.
  • Table 1 LODs for trivalent anions in the negative mode
  • Tables 2 through 8 list the LODs for the 18 trivalent anions in the positive mode when complexing with the 19 tetracations.
  • the detected complexes and mass to charge ratios are also listed.
  • the best LODs for the trivalent anions ranged from 7.5 pg to 18 ng.
  • each anion can form three possible complexes (+1, +2, +3) with tetraionic reagents.
  • different tetracations pair preferentially with different anionic species.
  • tetraionic pairing reagents CI and B4 gave the best LODs (380 pg and 400 pg) when the +3 complex was used for detection. Conversely, with other reagents, +1 or +2 complexes gave better signal-to- noise ratios.
  • +1 complexes generally gave the best signal to noise ratio compared to +2 and +3 complexes, such as hexacyanocobalte, 8-octanoyloxypyrene- 1,3,6-trisulfonate, 8-nonanoyloxypyrene-l,3,6-trisulfonate, tris(2,4-dimethyl-5- sulfophenyl)-phosphine and pyranine.
  • Anions typically giving the best LODs for +2 charged complexes were phosphate, 8-methoxypyrene-l,3,6-trisulfonate and chromium oxalate.
  • the prevalence of +2 complexes or +1 complexes can be related to the pKa of the conjugate acid of the trivalent anion. For example, as the pKa of HP0 4 " is 12.76, thus the protonated dianionic form of phosphate will be most abundant in the aqueous solution. This could be the reason why the +2 complexes (tetracation plus HP0 4 " ) produce a stronger signal than the +1 complex (tetracation with P0 4 " ). However, it should be noted that not all of the complexes are detectable. For example, the complexes of A3, B3, B4, B5 and D2 with hexanitrocobaltate were not observed.
  • metal containing trivalent anions generally have higher LODs than other anions.
  • sulfonate based anions typically had lower LODs than all the other anions.
  • 8-octanoyloxypyrene-l,3,6-trisulfonate and 8- nonanoyloxypyrene-l,3,6-trisulfonate have very similar structures, it is interesting to see that their LODs and best pairing reagents are different. This indicates that even a small change in structure can affect ion pairing. The difference may also be due to the different background noise at the mass to charge ratios of the complexes.
  • oxalomalic tricarboxylate had the highest LOD (2.5 ng) and nitrilotriacetic tricarboxylate gave the lowest LOD (125 pg).
  • trimetaphosphate had the lowest LOD (37 pg) and phosphate (380 pg) had the highest.
  • phosphonium-based tetracations generally produced better results than pure imidazolium-based tetracations in the SIM mode.
  • the imidazolium and phosphonium mixed tetracations showed moderate performance.
  • the best eight pairing agents for citrate are all phosphonium-based, while the four worst reagents were imidazolium tetracations.
  • pairing agents with more aromatic group substituents worked better for many aromatic anions while alkyl substituted phosphonium agents paired better with alkyl group containing anions.
  • Bl and B4 worked generally better than CI for anions with aromatic groups.
  • Bl, B4 and CI were selected, which are all phosphonium-based tetracations, as the ion pairing reagents that outperformed all others for the detection of trivalent anions. These are the first recommended cations to use for the detection of -3 anions. The cyclic phosphonium tetracation worked fairly well, but not as good as the best linear tetracations. This indicates that flexibility also may be an important feature for tetraionic pairing agents. This is analogous to what was found for trication ESTMS pairing agents.
  • Tetraionic pairing agents not only complex trivalent anions but also form cation-anion complexes when paired with singly charged and doubly charged anions. Therefore, two tetracations (Bl and CI) for the detection of four singly charged and four doubly charged anions were tested. The results are shown in Table 9. For monoanions, the results (i.e., sensitivities) found when using tetracations Bl and CI were not as good as those that found for the less charged pairing agents studied in earlier papers. For example, the best LOD for perfluorooctanate obtained by using a dicationic agent was 0.12 pg while Bl and CI only gave 150 pg and 90 pg LODs, respectively.
  • the LOD achieved by Bl (4.5 pg) was close to the best LOD achieved by a dicationic ion pairing agent (2.3 pg).
  • Bl and CI performed well for the detection of dianions.
  • the LODs of m-benzenedisulfonate obtained by Bl (12.5 pg) and CI (12.5 pg) are two times lower than the best LODs obtained with tricationic agents (32 pg). It has been shown that tetracations may be used as universal ion pairing agents for detecting mono-, di-, and trivalent anions.
  • Base peak indicates the mass/charge of the highest signal given by the complexes.
  • SRM mode may further reduce the detection limits of anions.
  • anion-cation complexes are first selected, and then disassociated into fragments.
  • the LODs were obtained by monitoring the strongest fragment peak.
  • the three best tetracations (Bl, B4 and CI) for the detection of trianions in the positive SRM mode were tested.
  • the SRM results are listed in Table 5. Typically 3 to 10 times better (lower) LODs were achieved.
  • the metal containing anions did not show immense improvements in the SRM mode. For example, the LOD of hexachlororhodate in the SRM mode (10 ng) was only slightly better than the LOD in the SIM mode (18 ng).
  • the LODs of some anions were lowered to the 100 fg range, for example hexacyanocobalte, 8-methoxypyrene-l,3,6-trisulfonate and tris(2,4-dimethyl-5- sulfophenyl)-phosphine.
  • the biggest improvements found by using the tetraionic agents are more than four orders of magnitude (as for hexacyanocobaltate).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)

Abstract

Sels liquides tétraioniques et leurs méthodes d'application dans les systèmes chromatographiques, par exemple dans des techniques de détection par spectrométrie de masse à ionisation par électrospray (ESI-MS).
PCT/US2010/058679 2009-12-04 2010-12-02 Sels liquides tétraioniques et leurs méthodes d'application WO2011068944A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26689209P 2009-12-04 2009-12-04
US61/266,892 2009-12-04

Publications (1)

Publication Number Publication Date
WO2011068944A1 true WO2011068944A1 (fr) 2011-06-09

Family

ID=43838061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/058679 WO2011068944A1 (fr) 2009-12-04 2010-12-02 Sels liquides tétraioniques et leurs méthodes d'application

Country Status (1)

Country Link
WO (1) WO2011068944A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102798687A (zh) * 2012-08-06 2012-11-28 中国科学院长春应用化学研究所 一种乌头类中成药的原位质量检测方法
JPWO2013172350A1 (ja) * 2012-05-14 2016-01-12 国立大学法人 東京大学 新規グラフェンナノ分散液及びその調製方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004668A1 (fr) * 1989-10-09 1991-04-18 Fabricom Air Conditioning S.A. Composition desinfectante et procede de desinfection
US20060025598A1 (en) 2004-07-23 2006-02-02 Advanced Separation Technologies Inc. High stability diionic liquid salts
US20080027231A1 (en) 2004-07-23 2008-01-31 Sigma-Aldrich Co. High stability diionic liquid salts
WO2008095069A2 (fr) * 2007-01-31 2008-08-07 Sigma-Aldrich Co. Sels polyioniques liquides extrêmement stables
WO2008110007A1 (fr) * 2007-03-12 2008-09-18 The Royal Institution For The Advancement Of Learning/Mcgill University Oligomères ioniques de type imidazolium

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004668A1 (fr) * 1989-10-09 1991-04-18 Fabricom Air Conditioning S.A. Composition desinfectante et procede de desinfection
US20060025598A1 (en) 2004-07-23 2006-02-02 Advanced Separation Technologies Inc. High stability diionic liquid salts
US20080027231A1 (en) 2004-07-23 2008-01-31 Sigma-Aldrich Co. High stability diionic liquid salts
WO2008095069A2 (fr) * 2007-01-31 2008-08-07 Sigma-Aldrich Co. Sels polyioniques liquides extrêmement stables
WO2008095064A2 (fr) * 2007-01-31 2008-08-07 Sigma-Aldrich Co. Sels diioniques liquides extrêmement stables
US20080210858A1 (en) 2007-01-31 2008-09-04 Armstrong Daniel W High Stability Polyionic Liquid Salts
WO2008110007A1 (fr) * 2007-03-12 2008-09-18 The Royal Institution For The Advancement Of Learning/Mcgill University Oligomères ioniques de type imidazolium

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013172350A1 (ja) * 2012-05-14 2016-01-12 国立大学法人 東京大学 新規グラフェンナノ分散液及びその調製方法
CN102798687A (zh) * 2012-08-06 2012-11-28 中国科学院长春应用化学研究所 一种乌头类中成药的原位质量检测方法
CN102798687B (zh) * 2012-08-06 2014-11-12 中国科学院长春应用化学研究所 一种乌头类中成药的原位检测方法

Similar Documents

Publication Publication Date Title
US8980643B2 (en) Dicationic liquid salts and methods of use thereof
Tan et al. Advances in analytical chemistry using the unique properties of ionic liquids
US8097721B2 (en) High stability polyionic liquid salts
US9958422B2 (en) Methods for quantitating water using ionic liquid salts
Hsieh Potential of HILIC‐MS in quantitative bioanalysis of drugs and drug metabolites
Xiu et al. Effective protein separation by coupling hydrophobic interaction and reverse phase chromatography for top-down proteomics
Chen et al. Evaluation of mobile phase composition for enhancing sensitivity of targeted quantification of oligonucleotides using ultra-high performance liquid chromatography and mass spectrometry: application to phosphorothioate deoxyribonucleic acid
JP7055634B2 (ja) 標識化グリコシルアミンの迅速調製およびそれを生成するグリコシル化生体分子の分析方法
Wolrab et al. Strong cation exchange-type chiral stationary phase for enantioseparation of chiral amines in subcritical fluid chromatography
US8742331B2 (en) Imidazolium-based liquid salts and methods of use thereof
EP2682396A1 (fr) Sels liquides diioniques de haute stabilité
Miková et al. At-line coupling of hollow fiber liquid-phase microextraction to capillary electrophoresis for trace determination of acidic drugs in complex samples
CN112955239B (zh) 用于极性分子分析的液相色谱/质谱方法
WO2011068944A1 (fr) Sels liquides tétraioniques et leurs méthodes d'application
US11173418B2 (en) Materials and methods for trap-elute mixed mode chromatography
CN111896648A (zh) 一种用高效液相色谱法分析制备mmae手性异构体的方法
Mei Matrix effects: causes and solutions
Hussain et al. Evaporation-free extraction and application in high-throughput bioanalysis by LC–MS-MS
Nováková UHPLC in modern bioanalysis
RU2574767C1 (ru) Адсорбент для газохроматографического разделения энантиомеров
JP2023161874A (ja) 移動相、及びイオン化可能な有機化合物の分離方法
EP4234062A2 (fr) Procédés d'ionisation par électronébulisation de glycanes modifiés par des fragments amphipathiques, fortement basiques
Snyder et al. Wiley, New York, 2007, pp. 19 21. 26. LR Snyder, Today's Chemist at Work, 5 (1996) 29. 27. PJ Schoenmakers, HAH Billiet, and L. de Galan, J. Chromatogr., 185 (1979) 179. 28. PJ Schoenmakers, HAH Billiet, andL. de Galan, J. Chromatogr., 218 (1981) 259.
Franco et al. Finding the Best Separation for Enantiomeric Mixtures.
Mallet et al. Optimized Workflow for API Process Impurities using 2D LC-MS/MS

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10787656

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10787656

Country of ref document: EP

Kind code of ref document: A1